Some 6 million Americans suffer from bipolar disorder, and many struggle to manage this debilitating illness with the treatments currently available.
Bipolar Network News is both an online clearinghouse of information about mood disorders, and a quarterly print and email publication. We provide updates on the latest research about bipolar disorder, gleaned from abstracts, meetings, and pre-publication sources. We hope to shed light on emerging trends in research and treatment of bipolar illness in order to help educate patients, family members, interested laypeople, physicians, and other professionals in the field. The newsletter is available free of charge to all who request it.
Although the editors of the BNN have made every effort to report accurate information, much of the work referenced here is in abstract or pre-publication form, and may not have received proper review by the scientific community at this time. Patients should consult with their physicians about any treatment decisions. Physicians should consult the published literature.
Editor-in-Chief: Robert M. Post, M.D.
Managing Editor: Moira McCauley
Dr. Post has consulted or spoken for the following pharmaceutical companies: Abbott, AstraZeneca, Bristol-Myers Squibb, Glaxo-SmithKline, Jansen, and Pfizer.
The opinions expressed on this site and in the newsletter are solely those of the editors, and do not represent the views of any scientific entity or foundation.
To subscribe or update your subscription, emailindicating whether you would like to receive the BNN via email or by mail and leaving either your email or mailing address. Note that we do not accept requests to subscribe friends or family members. Please have them contact us directly.
For comments or questions about the content of this site or the print publication, email.